Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inactivation of ADAMTS18
by aberrant promoter hypermethylation contribute to lung cancer progression
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-11-12
DOI
10.1002/jcp.27439
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Key Role of Epigenetics in Human Disease Prevention and Mitigation
- (2018) Andrew P. Feinberg NEW ENGLAND JOURNAL OF MEDICINE
- Lung cancer epigenetics: From knowledge to applications
- (2017) Michaël Duruisseaux et al. SEMINARS IN CANCER BIOLOGY
- Adamts18 deficiency promotes colon carcinogenesis by enhancing β-catenin and p38MAPK/ERK1/2 signaling in the mouse model of AOM/DSS-induced colitis-associated colorectal cancer
- (2017) Tiantian Lu et al. Oncotarget
- Epigenetic silencing of ADAMTS18 promotes cell migration and invasion of breast cancer through AKT and NF-κ B signaling
- (2017) Hongying Xu et al. Cancer Medicine
- The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches
- (2016) Andreas C. Joerger et al. Annual Review of Biochemistry
- Chromosome 16q genes CDH1, CDH13 and ADAMTS18 are correlated and frequently methylated in human lymphoma
- (2016) Lobna Alkebsi et al. Oncology Letters
- Epigenetics in lung cancer diagnosis and therapy
- (2015) Aditi Mehta et al. CANCER AND METASTASIS REVIEWS
- NBM-T-BMX-OS01, an Osthole Derivative, Sensitizes Human Lung Cancer A549 Cells to Cisplatin through AMPK-Dependent Inhibition of ERK and Akt Pathway
- (2015) Tian-Jun Chen et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma
- (2015) Xue-jun Shao et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway
- (2015) Xiang-Rong Shu et al. Diagnostic Pathology
- Hypermethylation of the 16q23.1 Tumor Suppressor Gene ADAMTS18 in Clear Cell Renal Cell Carcinoma
- (2015) Ben Xu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adenovirus-mediated LRIG1 expression enhances the chemosensitivity of bladder cancer cells to cisplatin
- (2015) ZEJUN YAN et al. ONCOLOGY REPORTS
- Naphthoquinone Derivative PPE8 Induces Endoplasmic Reticulum Stress in p53 Null H1299 Cells
- (2015) Jin-Cherng Lien et al. Oxidative Medicine and Cellular Longevity
- Role of ErbB Receptors in Cancer Cell Migration and Invasion
- (2015) Aline Appert-Collin et al. Frontiers in Pharmacology
- Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
- (2014) Claudia Fumarola et al. BIOCHEMICAL PHARMACOLOGY
- p53 as a target for the treatment of cancer
- (2014) Michael J. Duffy et al. CANCER TREATMENT REVIEWS
- Secreted Clusterin Gene Silencing Enhances Chemosensitivity of A549 Cells to Cisplatin Through AKT and ERK1/2 Pathwaysin Vitro
- (2014) Biyuan Zhang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer
- (2013) Xue-Pu Sun et al. FEBS Journal
- Activation of ERK1/2 and Akt is associated with cisplatin resistance in human lung cancer cells
- (2013) Mei Wang et al. JOURNAL OF CHEMOTHERAPY
- The Metalloprotease ADAMTS8 Displays Antitumor Properties through Antagonizing EGFR–MEK–ERK Signaling and Is Silenced in Carcinomas by CpG Methylation
- (2013) Gigi C.G. Choi et al. MOLECULAR CANCER RESEARCH
- The ErbB/HER family of protein-tyrosine kinases and cancer
- (2013) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Epigenetic biomarkers in lung cancer
- (2012) Triantafillos Liloglou et al. CANCER LETTERS
- Methyl methanesulfonate induces apoptosis in p53-deficient H1299 and Hep3B cells through a caspase 2- and mitochondria-associated pathway
- (2012) Ying Jiang et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer
- (2012) Vassiliki Papadimitrakopoulou Journal of Thoracic Oncology
- The Ubiquitin Peptidase UCHL1 Induces G0/G1 Cell Cycle Arrest and Apoptosis Through Stabilizing p53 and Is Frequently Silenced in Breast Cancer
- (2012) Tingxiu Xiang et al. PLoS One
- Development of a Quantitative Methylation-Specific Polymerase Chain Reaction Method for Monitoring Beta Cell Death in Type 1 Diabetes
- (2012) Mohamed I. Husseiny et al. PLoS One
- Akt signalling in health and disease
- (2011) Ingeborg Hers et al. CELLULAR SIGNALLING
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Mutational and Functional Analysis Reveals ADAMTS18 Metalloproteinase as a Novel Driver in Melanoma
- (2010) X. Wei et al. MOLECULAR CANCER RESEARCH
- ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis
- (2009) X. Lu et al. GENES & DEVELOPMENT
- Catalytic Domain Architecture of Metzincin Metalloproteases
- (2009) F. Xavier Gomis-Rüth JOURNAL OF BIOLOGICAL CHEMISTRY
- High-resolution melting analysis of ADAMTS18 methylation levels in gastric, colorectal and pancreatic cancers
- (2009) Zhi Li et al. MEDICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now